IBUPROFEN PM (diphenhydramine citrate, ibuprofen)

Safeway · tablet, film coated · NDC 21130-623

Listed in the FDA National Drug Code directory

IBUPROFEN PM is an over-the-counter medicine made available by Safeway, on the U.S. market since December 2025. It is marketed under an FDA approval (ANDA ANDA079113), so the FDA has reviewed its safety, effectiveness and manufacturing. A listing proves the product exists; it does not prove that a particular pack is genuine, so compare yours with the official description below.

What the genuine product looks like

From the official FDA label (version of Jan 2, 2026). Compare the colour, shape, imprint and packaging with what you have. Any difference is a reason to ask a pharmacist before taking it.

Product data on the label: IBUPROFEN PM diphenhydramine citrate, ibuprofen DIPHENHYDRAMINE CITRATE DIPHENHYDRAMINE IBUPROFEN IBUPROFEN SILICON DIOXIDE CROSCARMELLOSE SODIUM FD&C BLUE NO. 2 ALUMINUM LAKE HYDROXYPROPYL CELLULOSE, UNSPECIFIED FERROSOFERRIC OXIDE LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POLYVINYL ALCOHOL, UNSPECIFIED TALC TITANIUM DIOXIDE L050

Text on the package panel: Principal Display Panel COMPARE TO Advil ® PM active ingredients Signature SELECT ® IBUPROFEN PM IBUPROFEN 200 mg/DIPHENHYDRAMINE CITRATE 38 mg TABLETS Pain Reliever (NSAID)/Nighttime Sleep-Aid LOVE IT OR IT’S ON US 120 CAPLETS** **Capsule-shaped tablets Actual Size signture-select-ibuprofen-pm-carton-image.jpg

What it is for

Purposes Nighttime sleep-aid Pain reliever

Key warnings

Warnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: • hives • facial swelling • asthma (wheezing) • shock • skin reddening • rash • blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you • are age 60 or older • have had stomach ulcers or bleeding problems • take a blood thinning (anticoagulant) or steroid drug • take other drugs containing prescription or n…

Excerpts from the FDA label. Always read the leaflet in your pack and ask a pharmacist or doctor about your own situation.

Advertisement

Recalls of this product

No FDA recalls are recorded for NDC 21130-623. Recalls are listed in FDA enforcement reports from 2004 onward.

Most reported side effects for diphenhydramine citrate, ibuprofenReports to the FDA Adverse Event Reporting System (FAERS), all products with this ingredient
Fatigue8 reports
Nausea8 reports
Completed suicide5 reports
Abdominal distension4 reports
Diarrhoea4 reports
Hypoaesthesia4 reports
Insomnia4 reports
Joint swelling4 reports
Product use in unapproved indication4 reports
Vomiting4 reports
Show as table
ItemValue (reports)
Fatigue8
Nausea8
Completed suicide5
Abdominal distension4
Diarrhoea4
Hypoaesthesia4
Insomnia4
Joint swelling4
Product use in unapproved indication4
Vomiting4

These counts are reports, not proof that the medicine caused the problem. Popular medicines get more reports simply because more people take them. They are useful for spotting what to watch for, not for comparing medicines.

Official listing

Brand
IBUPROFEN PM
Generic name
diphenhydramine citrate, ibuprofen
Company
Safeway
Form
tablet, film coated
Route
oral
Type
HUMAN OTC DRUG
Category
ANDA
Listing valid to
Dec 31, 2027
Product NDC
21130-623

Active ingredients

Diphenhydramine Citrate
38 mg/1
Ibuprofen
200 mg/1

Packages (1)

The last part of the NDC identifies the pack size. Your box should show one of these.

21130-623-76 1 bottle in 1 carton (21130-623-76) / 120 tablet, film coated in 1 bottle

Think your pack is fake?

Stop taking it, keep the pack and receipt, and show it to a pharmacist. In the U.S., report it to FDA MedWatch; elsewhere, to your national medicines regulator. How to spot a fake medicine.

Source: openFDA (U.S. Food and Drug Administration) drug directory, labels, enforcement reports and FAERS, retrieved Nov 8, 2026. The FDA notes this data should not be relied on alone for medical decisions. Not medical advice.